1. Welcome to the Foot Health Forum community where you can ask about foot problems and get help, as well as be up-to-date with the latest foot health information. Only registered members can ask a question, but you do not need to register to respond and give help. Please become part of the community (here) and check out the shop.

Cryoablation of Morton?s Neuroma

Discussion in 'Podiatry Arena' started by Admin, May 21, 2016.

  1. Admin

    Admin Administrator Staff Member

    Percutaneous MR-Guided Cryoablation of Morton?s Neuroma: Rationale and Technical Details After the First 20 Patients
    Roberto Luigi Cazzato , Julien Garnon, Nitin Ramamurthy, Georgia Tsoumakidou, Jean Caudrelier, Marie-Aude Thenint, Pramod Rao, Guillaume Koch, Afshin Gangi
    CardioVascular and Interventional Radiology; pp 1-8; First online: 17 May 2016
    Quote:
    Objectives
    The purpose of this study is to discuss technical aspects and rationales of magnetic resonance (MR)-guided cryoablation (CA) of Morton?s neuroma (MN); preliminary clinical experience is also retrospectively reviewed.
    Methods
    Procedures were performed under local anaesthesia on an outpatient basis. Lesion size and location, procedural (technical success, procedural time, complications) and clinical outcomes (patient satisfaction according to a four-point scale, residual pain according to a 0?10 visual analogue scale and instances of ?stump neuroma?) were assessed via chart review and cross-sectional telephone survey after the 20th case.
    Results
    Twenty patients (15 female, 5 male; mean age 50.3 years) were included; 24 MN (mean size 12.7 mm) were treated. Technical success was 100 %. Mean procedural time was 40.9 ? 10.4 min (range 35?60). One minor complication (superficial cellulitis) was reported (4.2 %). Follow-up (mean 19.7 months) was available for 18/24 MN. Patient satisfaction on a per-lesion basis was as follows: ?completely satisfied? in 77.7 %, ?satisfied with minor reservations? in 16.6 % and ?satisfied with major reservations? in 5.7 % of cases. Mean pain score at last follow-up post-CA was 3.0. No instances of ?stump neuroma? were reported.
    Conclusions
    MR-guided CA of MN is a novel therapy which appears technically feasible. Clinical advantages of the procedure are high patient satisfaction, reduced risk of ?stump neuroma? syndrome and good patient tolerance on an outpatient basis. Further, prospective studies are needed to confirm these encouraging results.

    Continue reading...
     
Loading...

Share This Page